Picture of Haemonetics logo

HAE — Haemonetics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Haemonetics Corp expected to post earnings of 73  cents a share - Earnings Preview

* Haemonetics Corp  HAE.N   HAE  is expected to show a rise
in
quarterly revenue when it reports  results on February 8. 
    * The Boston Massachusetts-based  company is expected to
report  a
11.0% increase in revenue to $266.741 million from $240.37
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Haemonetics Corp is
for
earnings of 73 cents per share. For the same quarter last year,
the company reported earnings of 81 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Haemonetics
Corp
is $70​, about 34.2% above​ its last closing price
of $46.06. ​​​
    * 

This summary was machine generated February 4 at 12:13 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Haemonetics

See all news